Clinical Utility and Accuracy of Point-of-Care Testing for Anti-TNF Drug Monitoring and Loss of Response

Serum ADL and IFX POCT concentrations are comparable to ELISA and associated with LOR, indicating its clinical utility.

Authors

Publication Details

Journal
Inflammatory Bowel Diseases
Published
2025-04-22
DOI
https://doi.org/10.1093/ibd/izaf101
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Utility and Accuracy of Point-of-Care Testing for Anti-TNF Drug Monitoring and Loss of Response

Toer Stevens, Bayda Bahur, Kurtis R. Bray, Christoph Teichert et al.
Inflammatory Bowel Diseases
Inflammatory Bowel Disease
article

Clinical Utility and Accuracy of Point-of-Care Testing for Anti-TNF Drug Monitoring and Loss of Response

Toer Stevens, Bayda Bahur, Kurtis R. Bray, Christoph Teichert, Geert D’Haens, K Gecse, Suzanne I. Anjie
article en

Abstract

Serum ADL and IFX POCT concentrations are comparable to ELISA and associated with LOR, indicating its clinical utility.

Inflammatory Bowel DiseasesVol. 31(10)
Peace, Justice and strong institutions
Openalex Percentile: Top 89%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical Utility and Accuracy of Point-of-Care Testing for Anti-TNF Drug Monitoring and Loss of Response — Toer Stevens, Bayda Bahur, et al. · Inflammatory Bowel Diseases (2025) | TGRS Research Map | TGRS